Health · 31 Oct
GLP-1 Medicine | మార్కెట్లో కుప్పలు కుప్పలుగా కల్తీ జీఎల్పీ-1 మందులు.. అమెరికా ఎఫ్డీఏ హెచ్చరికలు..
AI summaryThe US FDA issued import alerts against two Chinese pharmaceutical manufacturers, Chengdu ShengNuo Bio-Pharm and Nanjing ChengAng Pharmaceutical, for sanitary deficiencies and quality control negligence during inspections. The alert, listed under 66-40, prevents these companies' products from entering the US market. The article notes that while these conditions were found, it does not confirm that the products have actually caused harm to patients.
1 outlet